Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03768765 · ClinicalTrials.gov registry record
Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)
A clinical trial, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- 144
- Enrollment target
NCT03768765: Clinical Trial study, sponsored by University of Kansas Medical Center.
NCT03768765 is a clinical trial that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03768765 was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- 144 participants
- Enrollment target
Study Summary
To determine if the prior prolonged use of medication, as a treatment for benign prostatic hyperplasia, reduces the efficacy of Holmium laser enucleation of the prostate (HoLEP) for patients with benign prostatic hyperplasia (BPH).
Primary Outcome
The primary objective is to determine if patients who undergo holmium laser surgery prior to being placed on long term medication for benign prostatic hyperplasia (BPH) have a greater improvement in their bladder function, as measured by urodynamics, when compared to patients who undergo holmium laser surgery after being placed on long term medication for BPH.
Interventions
- PROCEDURE Holmium Laser Prostate Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2024-08-27 |
Why NCT03768765 stopped before completion
NCT03768765 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Holmium Laser Prostate Surgery is the first listed.
NCT03768765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03768765 about?
NCT03768765 is a clinical study titled "Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)". To determine if the prior prolonged use of medication, as a treatment for benign prostatic hyperplasia, reduces the efficacy of Holmium laser enucleation of the prostate (HoLEP) for patients with benign prostatic hyperplasia (BPH).
What is the current status of trial NCT03768765?
This trial is currently terminated. The enrollment target is 144 participants. The study started on 2018-11-15. Estimated completion is 2024-08-27.
What interventions are being tested in trial NCT03768765?
The interventions under investigation include: Holmium Laser Prostate Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03768765?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI